Hepatic stellate cells as key target in liver fibrosis

T Higashi, SL Friedman, Y Hoshida - Advanced drug delivery reviews, 2017 - Elsevier
Progressive liver fibrosis, induced by chronic viral and metabolic disorders, leads to more
than one million deaths annually via development of cirrhosis, although no antifibrotic …

[HTML][HTML] Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets

CY Zhang, WG Yuan, P He, JH Lei… - World journal of …, 2016 - ncbi.nlm.nih.gov
Liver fibrosis is a reversible wound-healing process aimed at maintaining organ integrity,
and presents as the critical pre-stage of liver cirrhosis, which will eventually progress to …

Pharmacological intervention in hepatic stellate cell activation and hepatic fibrosis

HT Schon, M Bartneck… - Frontiers in …, 2016 - frontiersin.org
The activation and transdifferentiation of hepatic stellate cells (HSCs) into contractile, matrix-
producing myofibroblasts (MFBs) are central events in hepatic fibrogenesis. These …

Intercellular crosstalk of hepatic stellate cells in liver fibrosis: New insights into therapy

X Cai, J Wang, J Wang, Q Zhou, B Yang, Q He… - Pharmacological …, 2020 - Elsevier
Liver fibrosis is a dynamic wound-healing process characterized by the net accumulation of
extracellular matrix. There is no efficient antifibrotic therapy other than liver transplantation to …

Pathogenesis of liver fibrosis

V Hernandez-Gea, SL Friedman - Annual review of pathology …, 2011 - annualreviews.org
Liver fibrosis is a major cause of morbidity and mortality worldwide due to chronic viral
hepatitis and, more recently, from fatty liver disease associated with obesity. Hepatic stellate …

Hepatic stellate cells as a target for the treatment of liver fibrosis

R Bataller, DA Brenner - Seminars in liver disease, 2001 - thieme-connect.com
Following chronic liver injury of any etiology, there is progressive fibrosis. To date, removing
the causative agent is the only effective therapy to stop or even reverse liver fibrosis …

Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy

D Li, S Friedman - Journal of gastroenterology and hepatology, 1999 - Wiley Online Library
Hepatic fibrosis is a wound‐healing response to chronic liver injury, which if persistent leads
to cirrhosis and liver failure. Exciting progress has been made in understanding the …

Pathophysiology and treatment options for hepatic fibrosis: can it be completely cured?

A Khanam, PG Saleeb, S Kottilil - Cells, 2021 - mdpi.com
Hepatic fibrosis is a dynamic process that occurs as a wound healing response against liver
injury. During fibrosis, crosstalk between parenchymal and non-parenchymal cells …

Therapeutic potential of targeting regulatory mechanisms of hepatic stellate cell activation in liver fibrosis

K Baghaei, S Mazhari, S Tokhanbigli… - Drug discovery today, 2022 - Elsevier
Highlights•Hepatic stellate cell activation/myofibroblast transition is the main driver of liver
fibrosis.•Paracrine signals from adjacent cells induce stellate cell activation.•Alteration in …

Therapeutic targets in liver fibrosis

JA Fallowfield - American Journal of Physiology …, 2011 - journals.physiology.org
Detailed analysis of the cellular and molecular mechanisms that mediate liver fibrosis has
provided a framework for therapeutic approaches to prevent, slow down, or even reverse …